Citations (53)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Francesco Chiarelli & Daniele Di Marzio. (2008) Peroxisome proliferator-activated receptor-γ agonists and diabetes: Current evidence and future perspectives. Vascular Health and Risk Management 4:2, pages 297-304.
Read now
Read now
Bulent O Yildiz. (2004) Recent advances in the treatment of polycystic ovary syndrome. Expert Opinion on Investigational Drugs 13:10, pages 1295-1305.
Read now
Read now
Stefano Del Prato & Laura Volpe. (2004) Rosiglitazone plus metformin: combination therapy for Type 2 diabetes. Expert Opinion on Pharmacotherapy 5:6, pages 1411-1422.
Read now
Read now
M. P. Hermans & M. Buysschaert. (2004) PHARMACOLOGICAL TREATMENT OF TYPE 2 DIABETES. Acta Clinica Belgica 59:2, pages 59-66.
Read now
Read now
Articles from other publishers (49)
Roman Dąbrowski, Anna Wdowiak, Maria D. Contreras-Aguilar, Lorena Franco-Martinez, Alberto Muñoz-Prieto, Marek Szczubiał, Silvia Martinez-Subiela, Jose J. Ceron & Asta Tvarijonaviciute. (2020) Serum and salivary adiponectin dynamics in septic and non-septic systemic inflammation in a canine model. Veterinary Immunology and Immunopathology 219, pages 109961.
Crossref
Crossref
Bei Luo, Shuangkou Chen, Yinying Guo & Yuting Ren. 2020. Frontier Computing. Frontier Computing
746
753
.
Ruth Martis, Caroline A Crowther, Emily Shepherd, Jane Alsweiler, Michelle R Downie & Julie Brown. (2018) Treatments for women with gestational diabetes mellitus: an overview of Cochrane systematic reviews. Cochrane Database of Systematic Reviews 2018:8.
Crossref
Crossref
Michel Leandro Campos, Letícia Bonancio Cerqueira, Bruna Cristina Ulian Silva, Taísa Busaranho Franchin, Marina Rocha Galdino-Pitta, Ivan Rocha Pitta, Rosângela Gonçalves Peccinini & Roberto Pontarolo. (2018)
New Pioglitazone Metabolites and Absence of Opened-Ring Metabolites in New
N
-Substituted Thiazolidinedione
. Drug Metabolism and Disposition 46:6, pages 879-887.
Crossref
Crossref
Ruth Martis, Julie Brown, Jane Alsweiler, Michelle R Downie & Caroline A Crowther. (2016) Treatments for women with gestational diabetes mellitus: an overview of Cochrane systematic reviews. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Jie Wu, Jun-jie Wu, Lin-jun Yang, Li-xin Wei & Da-jin Zou. (2012) Rosiglitazone protects against palmitate-induced pancreatic beta-cell death by activation of autophagy via 5′-AMP-activated protein kinase modulation. Endocrine 44:1, pages 87-98.
Crossref
Crossref
Nagandla Kavitha, Somsubhra De & Sachchithanantham Kanagasabai. (2013) Oral Hypoglycemic Agents in pregnancy: An Update. The Journal of Obstetrics and Gynecology of India 63:2, pages 82-87.
Crossref
Crossref
Joshua P. Taygerly, Lawrence R. McGee, Steven M. Rubenstein, Jonathan B. Houze, Timothy D. Cushing, Yang Li, Alykhan Motani, Jin-Long Chen, Walter Frankmoelle, Guosen Ye, Marc R. Learned, Juan Jaen, Shichang Miao, Pieter B. Timmermans, Martin Thoolen, Patrick Kearney, John Flygare, Holger Beckmann, Jennifer Weiszmann, Michelle Lindstrom, Nigel Walker, Jinsong Liu, Donna Biermann, Zhulun Wang, Atsushi Hagiwara, Tetsuya Iida, Hisateru Aramaki, Yuki Kitao, Hisashi Shinkai, Noboru Furukawa, Jun Nishiu & Motonao Nakamura. (2013) Discovery of INT131: A selective PPARγ modulator that enhances insulin sensitivity. Bioorganic & Medicinal Chemistry 21:4, pages 979-992.
Crossref
Crossref
Ko Fujimori, Toshihiko Maruyama, Shinya Kamauchi & Yoshihiro Urade. (2012) Activation of adipogenesis by lipocalin-type prostaglandin D synthase-generated Δ12-PGJ2 acting through PPARγ-dependent and independent pathways. Gene 505:1, pages 46-52.
Crossref
Crossref
Asta Tvarijonaviciute, Oya Eralp, Meric Kocaturk, Zeki Yilmaz & Jose J. Ceron. (2011) Adiponectin and IGF-1 are negative acute phase proteins in a dog model of acute endotoxaemia. Veterinary Immunology and Immunopathology 140:1-2, pages 147-151.
Crossref
Crossref
Sanjeev Kumar, Christopher S Bryant, Sreedhar Chamala, Aamer Qazi, Shelly Seward, Jagannath Pal, Christopher P Steffes, Donald W Weaver, Robert Morris, John M Malone, Masood A Shammas, Madhu Prasad & Ramesh B Batchu. (2009) Ritonavir blocks AKT signaling, activates apoptosis and inhibits migration and invasion in ovarian cancer cells. Molecular Cancer 8:1.
Crossref
Crossref
Bobby D. Nossaman, Subramanyam N. Murthy & Philip J. Kadowitz. 2009. Cardiovascular Endocrinology. Cardiovascular Endocrinology
35
59
.
Giuseppe Derosa, Angela D'Angelo, Sibilla A.T. Salvadeo, Ilaria Ferrari, Alessia Gravina, Elena Fogari, Pamela Maffioli & Arrigo F.G. Cicero. (2008) Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone. Metabolism 57:11, pages 1552-1557.
Crossref
Crossref
Marcin Baranowski, Agnieszka Blachnio-Zabielska, Piotr Zabielski & Jan Gorski. (2008) Pioglitazone induces lipid accumulation in the rat heart despite concomitant reduction in plasma free fatty acid availability. Archives of Biochemistry and Biophysics 477:1, pages 86-91.
Crossref
Crossref
Asif R. Pathan, Anil Bhanudas Gaikwad, Bhoomi Viswanad & Poduri Ramarao. (2008) Rosiglitazone attenuates the cognitive deficits induced by high fat diet feeding in rats. European Journal of Pharmacology 589:1-3, pages 176-179.
Crossref
Crossref
Sam Bhathena. 2007. Fatty Acids in Foods and their Health Implications,Third Edition. Fatty Acids in Foods and their Health Implications,Third Edition
1145
1196
.
Makoto Hiromura, Akihiro Nakayama, Yusuke Adachi, Miyuki Doi & Hiromu Sakurai. (2007) Action mechanism of bis(allixinato)oxovanadium(IV) as a novel potent insulin-mimetic complex: regulation of GLUT4 translocation and FoxO1 transcription factor. JBIC Journal of Biological Inorganic Chemistry 12:8, pages 1275-1287.
Crossref
Crossref
G. Derosa, A. D’Angelo, P. D. Ragonesi, L. Ciccarelli, M. N. Piccinni, F. Pricolo, S. A. T. Salvadeo, L. Montagna, A. Gravina, I. Ferrari, S. Paniga & A. F. G. Cicero. (2007) Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with metformin. Internal Medicine Journal 37:2, pages 79-86.
Crossref
Crossref
Marcin Baranowski, Agnieszka Blachnio, Piotr Zabielski & Jan Gorski. (2007) Pioglitazone induces de novo ceramide synthesis in the rat heart. Prostaglandins & Other Lipid Mediators 83:1-2, pages 99-111.
Crossref
Crossref
Jade K.A. Hampel, Leon M. Brownrigg, Dayalan Vignarajah, Kevin D. Croft, Arun M. Dharmarajan, Jacqueline M. Bentel, Ian B. Puddey & Bu B. Yeap. (2006) Differential modulation of cell cycle, apoptosis and PPARγ2 gene expression by PPARγ agonists ciglitazone and 9-hydroxyoctadecadienoic acid in monocytic cells. Prostaglandins, Leukotrienes and Essential Fatty Acids 74:5, pages 283-293.
Crossref
Crossref
Giuseppe Derosa, Arrigo F.G. Cicero, Angela D'Angelo, Antonio Gaddi, Leonardina Ciccarelli, Mario N. Piccinni, Sibilla A.T. Salvadeo, Fabio Pricolo, Ilaria Ferrari, Alessia Gravina & Pietro D. Ragonesi. (2006) Effects of 1 Year of Treatment with Pioglitazone or Rosiglitazone Added to Glimepiride on Lipoprotein (a) and Homocysteine Concentrations in Patients with Type 2 Diabetes Mellitus and Metabolic Syndrome: A Multicenter, Randomized, Double-Blind, Controlled Clinical Trial. Clinical Therapeutics 28:5, pages 679-688.
Crossref
Crossref
H. Richardson, S. C. Campbell, S. A. Smith & W. M. Macfarlane. (2006) Effects of rosiglitazone and metformin on pancreatic beta cell gene expression. Diabetologia 49:4, pages 685-696.
Crossref
Crossref
Marta P Pereira, Olivia Hurtado, Antonio Cárdenas, Lisardo Boscá, José Castillo, Antoni Dávalos, José Vivancos, Joaquín Serena, Pedro Lorenzo, Ignacio Lizasoain & María A Moro. (2005)
Rosiglitazone and 15-deoxy-Δ
12,14
-prostaglandin J
2
Cause Potent Neuroprotection after Experimental Stroke through Noncompletely Overlapping Mechanisms
. Journal of Cerebral Blood Flow & Metabolism 26:2, pages 218-229.
Crossref
Crossref
Jae Hoon MoonHye Jin KimSoo Kyung KimWan Sub ShimEun Seuk KangYumie RheeChul Woo AhnSung Kil LimKyung Rae KimHyun Chul LeeBong Soo Cha. (2006) Long-term Effect of Pioglitazone Treatment in Patients with Type 2 Diabetes. The Journal of Korean Diabetes Association 30:4, pages 264.
Crossref
Crossref
Hyo-Jung ChooYoung-Gyu Ko. (2006) Type 2 Diabetes and Mitochondria. Journal of Korean Endocrine Society 21:4, pages 266.
Crossref
Crossref
Andreas Pfützner, Thomas Schöndorf, Daniela Seidel, Karl Winkler, Stephan Matthaei, Andreas Hamann & Thomas Forst. (2006) Impact of rosiglitazone on beta-cell function, insulin resistance, and adiponectin concentrations: results from a double-blind oral combination study with glimepiride. Metabolism 55:1, pages 20-25.
Crossref
Crossref
Xiangquan Li, Polly A. Hansen, Li Xi, Roshantha A.S. Chandraratna & Charles F. Burant. (2005) Distinct Mechanisms of Glucose Lowering by Specific Agonists for Peroxisomal Proliferator Activated Receptor γ and Retinoic Acid X Receptors. Journal of Biological Chemistry 280:46, pages 38317-38327.
Crossref
Crossref
Giuseppe Derosa, Arrigo F.G. Cicero, Antonio V. Gaddi, Leonardina Ciccarelli, Mario N. Piccinni, Sibilla Salvadeo, Fabio Pricolo, Elena Fogari, Morena Ghelfi, Ilaria Ferrari & Roberto Fogari. (2005) Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: A 12-month, double-blind, randomized clinical trial. Clinical Therapeutics 27:9, pages 1383-1391.
Crossref
Crossref
Sumner Burstein. (2005) PPAR-γ: A nuclear receptor with affinity for cannabinoids. Life Sciences 77:14, pages 1674-1684.
Crossref
Crossref
S Kaltenbach, H Staiger, M Weisser, C Haas, M Stumvoll, F Machicao & H-U Häring. (2005) Adiponectin receptor gene expression in human skeletal muscle cells is not regulated by fibrates and thiazolidinediones. International Journal of Obesity 29:7, pages 760-765.
Crossref
Crossref
Giuseppe Derosa, Antonio V. Gaddi, Mario N. Piccinni, Leonardina Ciccarelli, Sibilla Salvadeo, Emmanouil Peros, Morena Ghelfi, Ilaria Ferrari & Arrigo F. G. Cicero. (2005) Antithrombotic Effects of Rosiglitazone-Metformin versus Glimepiride-Metformin Combination Therapy in Patients with Type 2 Diabetes Mellitus and Metabolic Syndrome. Pharmacotherapy 25:5, pages 637-645.
Crossref
Crossref
G Derosa, AV Gaddi, L Ciccarelli, E Fogari, M Ghelfi, I Ferrari & AFG Cicero. (2016) Long-term Effect of Glimepiride and Rosiglitazone on Non-conventional Cardiovascular Risk Factors in Metformin-treated Patients Affected by Metabolic Syndrome: A Randomized, Double-blind Clinical Trial. Journal of International Medical Research 33:3, pages 284-294.
Crossref
Crossref
Antonio Ceriello, Don Johns, Mario Widel, David J. Eckland, Kathryn J. Gilmore & Meng H. Tan. (2005) Comparison of Effect of Pioglitazone With Metformin or Sulfonylurea (Monotherapy and Combination Therapy) on Postload Glycemia and Composite Insulin Sensitivity Index During an Oral Glucose Tolerance Test in Patients With Type 2 Diabetes. Diabetes Care 28:2, pages 266-272.
Crossref
Crossref
Terry S. Peters. (2016) Do Preclinical Testing Strategies Help Predict Human Hepatotoxic Potentials?. Toxicologic Pathology 33:1, pages 146-154.
Crossref
Crossref
Mark F. McCarty. (2005) Nutraceutical resources for diabetes prevention – an update. Medical Hypotheses 64:1, pages 151-158.
Crossref
Crossref
S. Jacob. 2005. Diabetes und Herz. Diabetes und Herz
354
362
.
J. Greeve. 2005. Atherosclerosis: Diet and Drugs. Atherosclerosis: Diet and Drugs
483
517
.
Louise Hutley, Wenda Shurety, Felicity Newell, Ross McGeary, Nicole Pelton, Jennifer Grant, Adrian Herington, Donald Cameron, Jon Whitehead & Johannes Prins. (2004) Fibroblast Growth Factor 1. Diabetes 53:12, pages 3097-3106.
Crossref
Crossref
Leanne Wilson-Fritch, Sarah Nicoloro, My Chouinard, Mitchell A. Lazar, Patricia C. Chui, John Leszyk, Juerg Straubhaar, Michael P. Czech & Silvia Corvera. (2004) Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone. Journal of Clinical Investigation 114:9, pages 1281-1289.
Crossref
Crossref
Leanne Wilson-Fritch, Sarah Nicoloro, My Chouinard, Mitchell A. Lazar, Patricia C. Chui, John Leszyk, Juerg Straubhaar, Michael P. Czech & Silvia Corvera. (2004) Mitochondrial remodeling in adipose tissue associated with obesity and treatment with rosiglitazone. Journal of Clinical Investigation 114:9, pages 1281-1289.
Crossref
Crossref
Ursula Meier & Axel M Gressner. (2004) Endocrine Regulation of Energy Metabolism: Review of Pathobiochemical and Clinical Chemical Aspects of Leptin, Ghrelin, Adiponectin, and Resistin. Clinical Chemistry 50:9, pages 1511-1525.
Crossref
Crossref
Hannah J Welters, Stuart C McBain, Moh Tadayyon, John H B Scarpello, Stephen A Smith & Noel G Morgan. (2004)
Expression and functional activity of PPAR
γ
in pancreatic
β
cells
. British Journal of Pharmacology 142:7, pages 1162-1170.
Crossref
Crossref
Brian N Finck. (2004) The role of the peroxisome proliferator-activated receptor alpha pathway in pathological remodeling of the diabetic heart. Current Opinion in Clinical Nutrition & Metabolic Care 7:4, pages 391-396.
Crossref
Crossref
Nam D. Tran, Stephen K. Hunter & Jerome Yankowitz. (2004) Oral Hypoglycemic Agents in Pregnancy. Obstetrical & Gynecological Survey 59:6, pages 456-463.
Crossref
Crossref
Giuseppe Derosa, Arrigo F.G Cicero, Antonio Gaddi, Pietro D Ragonesi, Elena Fogari, Gianandrea Bertone, Leonardina Ciccarelli & Mario N Piccinni. (2004) Metabolic effects of pioglitazone and rosiglitazone in patients with diabetes and metabolic syndrome treated with glimepiride: A twelve-month, multicenter, double-blind, randomized, controlled, parallel-group trial. Clinical Therapeutics 26:5, pages 744-754.
Crossref
Crossref
Michael Haap, Cornelia Siewecke, Claus Thamer, Jürgen Machann, Fritz Schick, Hans-U. Häring, Rolf M. Szeimies & Michael Stumvoll. (2004) Multiple Symmetric Lipomatosis. Diabetes Care 27:3, pages 794-795.
Crossref
Crossref
Andrew J. Ahmann & Matthew C. Riddle. (2004) What to do when two oral agents fail to control type 2 diabetes–a matter of opinion or a matter of fact?. The American Journal of Medicine 116:4, pages 276-278.
Crossref
Crossref
Christian Libersa, Sophie Gautier, Nabil Ait Said, Laurent Ferez & Jacques Caron. (2004) Insuffisances cardiaques d’origine médicamenteuse (en dehors des anthracyclines). Therapies 59:1, pages 127-142.
Crossref
Crossref
Patrick J. Boyle & Albert Marchetti. (2003) Introduction. Clinical Therapeutics 25, pages B1-B3.
Crossref
Crossref